{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of High-Dose Preoperative Glucocorticoids in Open Liver Resection"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "single-centre, double-blinded, parallel-group RCT"
      },
      "Participants": {
        "score": 2,
        "evidence": "Patients scheduled for open liver resection were randomised"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either 10 mg/kg methylprednisolone (high dose) or 8 mg dexamethasone (standard dose)"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to determine if a single high dose of preoperative glucocorticoid reduces complications"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the number of patients with complications in the postanaesthesia care unit (PACU), measured during the PACU stay"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using block randomisation with allocation concealment via sealed opaque envelopes"
      },
      "Blinding": {
        "score": 3,
        "evidence": "All participants, trial personnel, and outcome assessors were blinded"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 174 patients were randomised (88 to high-dose, 86 to standard-dose)"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "analysed using an intention-to-treat approach"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Complications occurred in 51 patients (58%) in the high-dose group and 58 (67%) in the standard-dose group (risk ratio 0.86, 95% CI 0.68 to 1.08; P = 0.213)"
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events occurred in 48 patients (45%) in the high-dose group and 49 (43%) in the standard-dose group"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "NCT03403517; EudraCT 2017\u2013002652-81"
      },
      "Funding": {
        "score": 1,
        "evidence": "Supported by the Research Fund at Rigshospitalet and Departments of Anaesthesiology and Gastrointestinal Surgery and Transplantation, Centre for Cancer and Organ Diseases, Rigshospitalet Copenhagen University Hospital, Denmark"
      }
    },
    "total_score": 25,
    "max_score": 25
  },
  "model": "gpt-4o"
}